ERBB2 and neoplasm: Similar to patient’s tumor samples, dual HER2 blockade in cell lines led to a significant relative increase in Luminal A and normal-like signature scores, and a relative decrease in proliferation, HER2-E, Luminal B and Basal-like signature scores (Fig. 2c).